Amy Smith

3.8k total citations
43 papers, 1.0k citations indexed

About

Amy Smith is a scholar working on Genetics, Molecular Biology and Neurology. According to data from OpenAlex, Amy Smith has authored 43 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Genetics, 18 papers in Molecular Biology and 12 papers in Neurology. Recurrent topics in Amy Smith's work include Glioma Diagnosis and Treatment (25 papers), Neuroblastoma Research and Treatments (9 papers) and Brain Metastases and Treatment (6 papers). Amy Smith is often cited by papers focused on Glioma Diagnosis and Treatment (25 papers), Neuroblastoma Research and Treatments (9 papers) and Brain Metastases and Treatment (6 papers). Amy Smith collaborates with scholars based in United States, Canada and United Kingdom. Amy Smith's co-authors include Nicholas K. Foreman, Anthony T. Yachnis, Linda Jacobson, William E. Hathaway, Marilyn J. Manco‐Johnson, Brian Miller, David W. Pincus, Éric Bouffet, Stephen Kayiaros and Erich O. Richter and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neuroscience and Cancer Research.

In The Last Decade

Amy Smith

39 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy Smith United States 20 482 346 296 165 153 43 1.0k
Anu Banerjee United States 16 597 1.2× 282 0.8× 355 1.2× 152 0.9× 114 0.7× 32 956
Lindsey M. Hoffman United States 20 558 1.2× 432 1.2× 254 0.9× 186 1.1× 255 1.7× 60 1.1k
F. Pichon France 12 514 1.1× 347 1.0× 371 1.3× 263 1.6× 123 0.8× 27 921
C. Edan France 15 580 1.2× 314 0.9× 324 1.1× 234 1.4× 151 1.0× 29 1.1k
Antony Michalski United Kingdom 16 560 1.2× 475 1.4× 254 0.9× 211 1.3× 130 0.8× 37 983
Kyung Gi Cho South Korea 20 330 0.7× 245 0.7× 311 1.1× 228 1.4× 139 0.9× 66 1.1k
Odile Lejars France 16 416 0.9× 328 0.9× 343 1.2× 298 1.8× 139 0.9× 28 980
Kevin X. Liu United States 20 233 0.5× 359 1.0× 284 1.0× 248 1.5× 302 2.0× 73 1.3k
George C. Bobustuc United States 13 221 0.5× 193 0.6× 365 1.2× 219 1.3× 138 0.9× 24 983
David Malkin Canada 20 321 0.7× 481 1.4× 209 0.7× 238 1.4× 370 2.4× 48 1.3k

Countries citing papers authored by Amy Smith

Since Specialization
Citations

This map shows the geographic impact of Amy Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Smith more than expected).

Fields of papers citing papers by Amy Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Smith. The network helps show where Amy Smith may publish in the future.

Co-authorship network of co-authors of Amy Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Smith. A scholar is included among the top collaborators of Amy Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Smith. Amy Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Smith, Amy, Shelly Lensing, Arzu Onar‐Thomas, et al.. (2024). EPEN-29. IS THE OUTCOME OF SUPRATENTORIAL EPENDYMOMA WITH ZFTA FUSION REALLY POOR?. Neuro-Oncology. 26(Supplement_4). 0–0. 1 indexed citations
3.
Leary, Sarah, Arzu Onar‐Thomas, Jason Fangusaro, et al.. (2023). Children's Oncology Group's 2023 blueprint for research: Central nervous system tumors. Pediatric Blood & Cancer. 70(S6). e30600–e30600. 5 indexed citations
4.
Tilburg, Cornelis M. van, Lindsay Kilburn, Erin Crotty, et al.. (2023). LOGGIC/FIREFLY-2: A phase 3, randomized trial of tovorafenib vs. chemotherapy in pediatric and young adult patients with newly diagnosed low-grade glioma harboring an activating RAF alteration.. Journal of Clinical Oncology. 41(16_suppl). TPS10067–TPS10067. 4 indexed citations
5.
Trippett, Tanya, Helen Toledano, Quentin Campbell Hewson, et al.. (2022). Cobimetinib in Pediatric and Young Adult Patients with Relapsed or Refractory Solid Tumors (iMATRIX-cobi): A Multicenter, Phase I/II Study. Targeted Oncology. 17(3). 283–293. 30 indexed citations
6.
Lindsay, Holly, Maura Massimino, Shivaram Avula, et al.. (2022). Response assessment in paediatric intracranial ependymoma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group. The Lancet Oncology. 23(8). e393–e401. 20 indexed citations
7.
Bertrand, Kelsey C., et al.. (2020). Weighing ependymoma as an epigenetic disease. Journal of Neuro-Oncology. 150(1). 57–61. 3 indexed citations
8.
Smith, Amy, et al.. (2018). Bundled Payments for Care Improvement in the Private Sector: A Win for Everyone. The Journal of Arthroplasty. 33(8). 2362–2367. 23 indexed citations
9.
Fay‐McClymont, Taryn B., Danielle M. Ploetz, Karin S. Walsh, et al.. (2017). Long-term neuropsychological follow-up of young children with medulloblastoma treated with sequential high-dose chemotherapy and irradiation sparing approach. Journal of Neuro-Oncology. 133(1). 119–128. 31 indexed citations
10.
Bartels, Ute, Johannes Wolff, Lia Gore, et al.. (2014). Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine glioma. Neuro-Oncology. 16(11). 1554–1559. 42 indexed citations
11.
Gore, Lia, Tanya Trippett, Howard M. Katzenstein, et al.. (2013). A Multicenter, First-in-Pediatrics, Phase 1, Pharmacokinetic and Pharmacodynamic Study of Ridaforolimus in Patients with Refractory Solid Tumors. Clinical Cancer Research. 19(13). 3649–3658. 19 indexed citations
12.
Silver, Daniel J., Florian A. Siebzehnrübl, Anthony T. Yachnis, et al.. (2013). Chondroitin Sulfate Proteoglycans Potently Inhibit Invasion and Serve as a Central Organizer of the Brain Tumor Microenvironment. Journal of Neuroscience. 33(39). 15603–15617. 100 indexed citations
13.
14.
Trippett, Tanya, Amy Smith, Kathleen Neville, et al.. (2013). Abstract B81: Phase I/II trial of vorinostat in combination with etoposide in pediatric patients with relapsed/refractory solid tumors.. Molecular Cancer Therapeutics. 12(11_Supplement). B81–B81.
15.
Galloway, Thomas J., et al.. (2011). Second Tumors in Pediatric Patients Treated With Radiotherapy to the Central Nervous System. American Journal of Clinical Oncology. 35(3). 279–283. 30 indexed citations
16.
Madden, Jennifer R., Andrew M. Donson, Arthur K. Liu, et al.. (2010). Radiation-induced Glioblastoma Multiforme in Children Treated for Medulloblastoma With Characteristics of Both Medulloblastoma and Glioblastoma Multiforme. Journal of Pediatric Hematology/Oncology. 32(7). e272–e278. 10 indexed citations
17.
Amdur, Robert J., Christopher G. Morris, Thomas J. Galloway, et al.. (2010). Intracranial ependymomas treated with radiotherapy: long-term results from a single institution. Journal of Neuro-Oncology. 102(3). 451–457. 19 indexed citations
18.
Brown, Jessica, Douglas W. Burton, Leonard J. Deftos, et al.. (2007). Congenital Craniopharyngioma and Hypercalcemia Induced by Parathyroid Hormone-Related Protein. Endocrine Practice. 13(1). 67–71. 6 indexed citations
19.
Pincus, David W., et al.. (2006). Brainstem stereotactic biopsy sampling in children. Journal of Neurosurgery Pediatrics. 104(2). 108–114. 69 indexed citations
20.
Trobaugh‐Lotrario, Angela D., Amy Smith, & Lorrie F. Odom. (2002). Vincristine neurotoxicity in the presence of hereditary neuropathy. Medical and Pediatric Oncology. 40(1). 39–43. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anu Banerjee Breakdown of academic impact, for papers by Lindsey M. Hoffman Breakdown of academic impact, for papers by F. Pichon Breakdown of academic impact, for papers by C. Edan Breakdown of academic impact, for papers by Antony Michalski Breakdown of academic impact, for papers by Kyung Gi Cho Breakdown of academic impact, for papers by Odile Lejars Breakdown of academic impact, for papers by Kevin X. Liu Breakdown of academic impact, for papers by George C. Bobustuc Breakdown of academic impact, for papers by David Malkin
Rankless by CCL
2026